Concordance of MTOR Pathway Mutations and the Diagnosis of Renal Low-Grade Oncocytic Tumor (LOT).

MLA

Siegmund, Stephanie E., et al. “Concordance of MTOR Pathway Mutations and the Diagnosis of Renal Low-Grade Oncocytic Tumor (LOT).” International Journal of Surgical Pathology, vol. 32, no. 2, Apr. 2024, pp. 316–30. EBSCOhost, https://doi.org/10.1177/10668969231178032.

APA

Siegmund, S. E., Al-Obaidy, K. I., Tsai, H. K., Idrees, M. T., Akgul, M., Acosta, A. M., & Hirsch, M. S. (2024). Concordance of MTOR Pathway Mutations and the Diagnosis of Renal Low-Grade Oncocytic Tumor (LOT). International Journal of Surgical Pathology, 32(2), 316–330. https://doi.org/10.1177/10668969231178032

Chicago

Siegmund, Stephanie E., Khaleel I. Al-Obaidy, Harrison K. Tsai, Muhammad T. Idrees, Mahmut Akgul, Andres M. Acosta, and Michelle S. Hirsch. 2024. “Concordance of MTOR Pathway Mutations and the Diagnosis of Renal Low-Grade Oncocytic Tumor (LOT).” International Journal of Surgical Pathology 32 (2): 316–30. doi:10.1177/10668969231178032.